CureDuchenne, led by CEO Debra Miller, is at the forefront of research for Duchenne muscular dystrophy, which is a rare and fatal neuromuscular disease.

It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession sparked by the ongoing global trade war. Most bigwigs came out with important ...

The global regenerative medicine market is poised for exponential growth over the coming decade. Valued at approximately USD 9,802.5 million in 2025, the market is projected to reach a staggering USD ...